FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Analogue topics
Carbon Dioxide
Amino Acid
Radio Signal
Inorganic Compounds
Hydrogen Production From Water
Electrolysis
Semiconductor
High Energy
Semiconductor Material
Transmitter
Synchronization
Concurrent
Surfactant
Hyperglycemia
Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Analogue patents



      
           
This page is updated frequently with new Analogue-related patent applications. Subscribe to the Analogue RSS feed to automatically get the update: related Analogue RSS feeds. RSS updates for this page: Analogue RSS RSS


Cyclosporine analogue mixtures and their use as immunomodulating agents

Continuous-time mash sigma-delta analogue to digital conversion

Date/App# patent app List of recent Analogue-related patents
12/18/14
20140371456
 Enzymatic transamination of cyclopamine analogs patent thumbnailnew patent Enzymatic transamination of cyclopamine analogs
Provided are processes for the synthesis of amino analogues from ketone starting materials.. .
12/18/14
20140371193
 Organometallic complexes as therapeutic agents patent thumbnailnew patent Organometallic complexes as therapeutic agents
This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use.
12/18/14
20140370082
 Cyclosporine analogue mixtures and their use as immunomodulating agents patent thumbnailnew patent Cyclosporine analogue mixtures and their use as immunomodulating agents
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine a. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives.
12/18/14
20140369624
 Flow imaging patent thumbnailnew patent Flow imaging
A system suitable for reducing static or slow moving echoes from acoustic boundaries in a system such as pipe walls, blood vessels, tissue structures so that an image from flowing or time varying media such as water, oil, blood etc may be imaged more clearly, the system including an analogue-to-digital converter for digitizing a received analogue signal from a detector, means for digitally separating static or slow moving components of the digital signal, a digital-to-analogue converter to provide an analogue version of the separated static or slow moving components of the signal, and a subtractor to subtract the analogue version of the static or the slow moving components of the signal from an analogue signal received from a detector to produce an analogue signal corresponding to the remaining flow components of the signal.. .
12/18/14
20140368368
 Continuous-time mash sigma-delta analogue to digital conversion patent thumbnailnew patent Continuous-time mash sigma-delta analogue to digital conversion
Continuous-time mash sigma-delta adc with a first modulator with 1.5 bit and a second modulator with 1 bit each receiving also the feedback from the other modulator. Sampling is at higher rate at the second modulator and decimation is performed before summing its output to the output of the first modulator..
12/11/14
20140364836
 Pharmaceutical compositions for the treatment of inner ear disorders patent thumbnailPharmaceutical compositions for the treatment of inner ear disorders
The present invention provides compositions containing (i) a pharmaceutically active agent selected from a group consisting of an arylcycloalkyamine of a derivative, analogue or pharmaceutically active salt thereof, and (ii) a biocompatible polymer or a combination of biocompatible polymers. The compositions or medicaments containing these compositions may be used for the prevention and/or treatment of inner ear diseases, e.g.
12/11/14
20140362763
 Wireless communication system and method and expansion unit of flat network architecture patent thumbnailWireless communication system and method and expansion unit of flat network architecture
Disclosed are a wireless communication system and method and an expansion unit of a flat network architecture. The wireless communication system comprises at least one baseband signal source, an expansion unit (eu) and at least one remote radio unit (ru) connected to the eu.
12/11/14
20140361831
 Amplifier device and method for activating an amplifier device or the amplifier unit patent thumbnailAmplifier device and method for activating an amplifier device or the amplifier unit
Known types of amplifiers include so-called class d amplifiers, which first use a pulse-width modulator to convert an analogue signal into a pulse-width modulated switching signal, which is then amplified and subsequently converted back into a continuously variable voltage via a filter. This type of amplifier is particularly energy-efficient and is therefore preferably used for high-power amplifiers.
12/11/14
20140359950
 Dyeing of keratin fibers using indole analogue patent thumbnailDyeing of keratin fibers using indole analogue
The problem is to provide a means for effectively dyeing keratin fibers while retaining high safety. Provided are a dyeing method and a dyeing agent, which include a combination of an oxidation dyeing agent consisting of an indole analogue and a bilirubin oxidase derived from myrothecium verrucaria or bacillus subtilis..
12/04/14
20140358489
 Non-linear parameter measuring method and system strong to noise patent thumbnailNon-linear parameter measuring method and system strong to noise
A nonlinearity parameter measuring method and system is configured to separately process a signal of a fundamental wave and second harmonic wave that went through a probe attached to a specimen using a circuit including an analogue band pass filter and intermediate frequency amplifier, and minimize the effects caused by noise, thereby measuring an exact nonlinearity parameter.. .
12/04/14
20140357872
New organocatalytic synthesis of chiral pyrazolidines and their analogues
Disclosed herein is a highly enantio—(75 to 98% ee)and diastereoselective (99 to 100% de)synthesis of functionalised pyrazolidines via tandem a-amination-corey chaykovsky reaction of alpha unsubstituted aldehydes.. .
12/04/14
20140357725
Terpene analogues and uses thereof for treating neurological conditions
Wherein: y is a c1 to c20 alkylene, c═o, so, so2, or absent; x is h, or1, n—(r2)2, a c1 to c20 alkyl, or a heterocyclyl (for example, heteroaryl), wherein when y is absent x is not h; r1 is h, a c1 to c20 alkyl, or a ch2-aryl; r2 is independently h, a c1 to c20 alkyl, aryl, or1, cn or c(═o)—r3; r3 is a substituted or unsubstituted c1 to c20 alkyl, or a aryl; w is h, c1 to c20 alkyl, or aryl; and z is c1 to c20 alkylene; or a pharmaceutically acceptable isomer, salt or ester thereof. These terpene analogues are useful in treating pain and can also be used to treat other electrical disorders in the central and peripheral nervous system..
12/04/14
20140357628
Therapeutic compounds
Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof, with the proviso that the compound is no tranilast.. .
11/27/14
20140350416
Cables for patient monitoring and related systems with integrated front end
Patient monitoring systems can include a system for transmitting information from a patient parameter sensor to a patient monitor. The system can include an analogue-to-digital converter close to the patient parameter sensor and can transmit digital signals through a cable to the patient monitor..
11/27/14
20140350288
Synthesis of galanal compounds and analogues thereof
The present disclosure provides methods of preparing glucagon-like peptide-1 (glp-1) receptor modulators, such as compounds of formula (ii) or (vi), or intermediates thereof. The compounds that may be prepared by the described methods are useful for regulating blood glucose levels and/or treating a disease mediated by a glp-1 receptor (e.g., diabetes)..
11/27/14
20140349993
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.
11/20/14
20140343002
Method of lowering glycemic index of foods
A method of delaying digestion by an animal or a human of carbohydrates in food, comprising administering an effective amount of one or more flavonoids to the animal or human in conjunction with the food, wherein the flavonoids are selected from luteolin, apigenin, tricin and their pharmaceutically acceptable analogues and derivatives.. .
11/20/14
20140342932
Functional cell surface display of ligands for the insulin and/or insulin growth factor 1 receptor and applications thereof
Systems for making, identifying, and selecting recombinant cells that express a ligand for the insulin receptor (ir) or insulin growth factor i (igf-1) receptor are described. In general, libraries of recombinant cells are constructed that are capable of displaying a plurality of ligand molecules on the cell surface.
11/20/14
20140342042
Method of lowering glycemic index of foods
A method of delaying digestion by an animal or a human of carbohydrates in food, comprising administering an effective amount of one or more flavonoids to the animal or human in conjunction with the food, wherein the flavonoids are selected from luteolin, apigenin, tricin and their pharmaceutically acceptable analogues and derivatives.. .
11/20/14
20140342002
Particulate materials
Embodiments of the invention relate to particles of active substances, methods for preparing the particles, formulations containing the particles, and metered dose inhalers containing such particles or formulations. In one embodiment, a composition of an aerosol formulation is provided and contains a particulate active substance of non-micronized, solid particles having a mass median aerodynamic diameter of less than 10 μm suspended in a hydrofluorocarbon fluid vehicle at a concentration within a range from about 0.2% w/v to about 5% w/v.
11/13/14
20140337400
Integrated quantum-random noise generator using quantum vacuum states of light
An integrated quantum random noise source includes a substrate, an optical oscillator that may be integral to the substrate coupled by an optical waveguide to an optical directional coupler. The optical directional coupler has two outputs that are coupled by optical waveguides to a pair of photodetectors that are part of a balanced photodetector.
11/13/14
20140336118
Polypeptide for the protection against heart ischemia-reperfusion injury
A peptide of the formula r1-nh-haegtftsdvssylegqaakefiawlvk-conr2r3 wherein r=h or an organic compound comprising from 1 to 10 carbon atoms and r2 r3=independently h or an alkyl group of 1 to 4 carbon atoms; or certain analogues of said glp-1 peptide can be used for the treatment and prophylaxis of heart ischemia-reperfusion injury. .
11/13/14
20140333309
Electronic marker locator systems and methods
A locator for determining the depth of a buried electromagnetic marker includes a transmission antenna and two reception antennas. The locator has a major axis and is configured.
11/06/14
20140330223
Transdermal therapeutic system for administering fentanyl or an analogue thereof
According to the invention a transdermal therapeutic system for administering fentanyl or an analogue thereof through the skin is provided that has a pressure-sensitive adhesive matrix layer containing a mixture of two polyisobutylenes with specific storage moduli.. .
11/06/14
20140330006
Functionally-modified oligonucleotides and subunits thereof
Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mrna splice products produces beneficial therapeutic effects..
11/06/14
20140329883
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
The invention provides pharmaceutical compositions comprising short single stranded oligonucleotides, of length of between 8 and 26 nucleobases which are complementary to human micrornas selected from the group consisting of mir19b, mir21, mir122a, mir155 and mir375. The short oligonucleotides are particularly effective at alleviating mirna repression in vivo.
11/06/14
20140329745
Human insulin analogue and acylated derivative thereof
The present invention provides a human insulin analogue, an acylated derivative thereof and a physiologically acceptable salt. The present invention further provides a preparation method for the insulin analogue and an application of the insulin analogue as a therapeutic agent, and particularly as a diabetes mellitus therapeutic agent..
11/06/14
20140329740
Anti-infective hydroxy-phenyl-benzoates and methods of use
The invention provides a method for preventing or treating a disease caused by an extracellular microorganism, said method comprising systemically administering to a subject in need thereof a prophylactically or therapeutically effective amount of a salicylic acid (sal) or a sal analogue. The extracellular microorganism can be of the bacterial genus staphylococcus, for example, staphylococcus aureus.
11/06/14
20140328943
Insulin compositions and method of making a composition
The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin asp b28 human insulin..
11/06/14
20140328792
Methods and compositions for treating and preventing viral infections
A method of treating or preventing a systemic viral infection in a mammal by administering a pharmaceutically acceptable composition selected from the group consisting of squalamine, an active isomer thereof, and an active analogue thereof, via a dosing regimen that delivers effective antiviral concentrations of squalamine. Also compositions for achieving the systemic antiviral effect..
10/30/14
20140323507
Mycophenolic acid analogues as anti-tumor chemosensitizing agents
In some embodiments, the present invention provides methods of treating a tumor in a subject. In some embodiments, the methods may include a step of administering to the subject a therapeutic composition that comprises: (a) mycophenolic acid, an analogue thereof, or a derivative thereof; and (b) at least one anti-neoplastic agent.
10/30/14
20140323427
Uridine and uridine analogues for treatment of specific lung diseases, namely copd and pulmonary fibrosis
The present invention relates to the new indications of chronic obstructive pulmonary disease (copd) and idiophathic lung fibrosis (ipf) for uridine and uridine analogues.. .
10/30/14
20140323425
Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment
The present invention describes the use of nucleoside analogues for the treatment of viral infections, in particular of an hiv infection, and also compositions comprising at least one of these analogues, and a method for evaluating the sensitivity to said treatment.. .
10/30/14
20140323398
Ultra-concentrated rapid-acting insulin analogue formulations
A pharmaceutical formulation comprises insulin having a variant insulin b-chain polypeptide containing an ortho-monofluoro-phenylalanine substitution at position b24 in combination with a substitution of an amino acid containing an acidic side chain at position b10, allowing the insulin to be present at a concentration of between 0.6 mm and 3.0 mm. The formulation may optionally be devoid of zinc.
10/30/14
20140322302
Therapeutic peptides
Therapeutic peptides having guanylyl cyclase c agonist activity are disclosed. The therapeutic peptides are analogues of the e.
10/30/14
20140320546
Organic light emitting diode display and method for driving the same
Provided is an organic light emitting diode display including a display panel having data lines, gate lines, and pixels disposed in a matrix form in a crossing region of the data lines and the gate lines, a gamma reference voltage adjustment unit that calculates an weighted average picture level of digital video data, adjusts gamma reference voltages so that peak luminance of the display panel is reduced as the weighted average picture level is increased, and outputs the adjusted gamma reference voltages, a data driving circuit converting the digital video data into analogue data voltages by using the gamma reference voltages, and supplying the data voltages to the data lines, and a gate driving circuit sequentially outputting gate pulses to the gate lines.. .
10/30/14
20140320100
Converter circuit and method for converting an input voltage to an output voltage
A converter circuit is described comprising a switch circuit configured to provide an output voltage, a control circuit comprising an analogue control portion and a digital control portion and a noise generator configured to generate white noise, wherein the noise generator is configured to supply the generated white noise to the digital control portion of the control circuit and wherein the control circuit is configured to control the switch circuit based on the white noise.. .
10/30/14
20140319415
Methods of incorporating amino acid analogues into a protein
The present invention provides a novel use of a spp system for replacing natural amino acid residues with non-naturally occurring amino acids in a protein or peptide, using cell based expression system.. .
10/23/14
20140316137
Coelenterazine analogues and coelenteramide analogues
Coelenterazine analogs with different luminescence properties from conventional ones and coelenteramide analogs with different fluorescence properties from conventional ones have been desired. The invention provides coelenterazine analogs modified at the 8-position of coelenterazine and coelenteramide analogs modified at the 2- or 3-position of coelenteramide..
10/23/14
20140315800
Glycosylated polypeptide and drug composition containing said polypeptide
[problem] to provide a glycosylated polypeptide having affinity to somatostatin receptors and, compared to somatostatins, having improved in-blood stability. [solution] the glycosylated polypeptide is characterized by at least two amino acids in a somatostatin or an analogue thereof being replaced by glycosylated amino acids..
10/23/14
20140315798
Chemically and thermodynamically stable insulin analogues and improved methods for their production
The subject matter of this invention is directed towards chemically and thermodynamically stable single-chain insulin (sci) analogues that are resistant to deamidation and fibrillation. The invention further discloses improved methods for the recombinant expression, purification and refolding of sci..
10/23/14
20140314904
Pre-slaughter diet including methionine
The present invention provides novel method for improving the tenderness of meat (e.g. Pork, beef and poultry).
10/16/14
20140309305
Hypertension reducing composition
A composition effective to relax smooth muscles in an individual in an altered state is described. The composition includes a dosage of gaba or gaba-a analogue, and a dosage of at least one of an ace inhibitor and an arb combined with the dosage of gaba or gaba-a analogue into a deliverable form..
10/16/14
20140308347
Cationic antibacterial composition
The present invention relates to compounds that are cationic vancomycin analogues and their compositions. Method of making the compounds and their use as medicament for the treatment of bacterial infection are also disclosed..
10/16/14
20140307248
Distance-measuring device
The invention relates to an electro-optical distance-measuring device, more particularly a laser rangefinder, with a transmitting unit for transmitting intensity-modulated optical radiation, a receiving unit for receiving a portion of the optical radiation reflected back from a target in a photosensitive electrical component and converting it into an electrical received signal, an input filter for filtering the received signal, an analogue-to-digital converter for digitising the filtered received signal and an electronic analysis unit that calculates the distance from the rangefinder to the target object on the basis of a signal propagation time using the digitised received signal. The input filter is implemented as a time-discrete and continuous-value filter structure, more particularly a digital filter structure..
10/16/14
20140306690
Apparatus for current measurement
A voltage to current converter is provided for use with a current measuring device, said current measuring device being operable to provide an output voltage which is an analogue of a current to be measured. The converter is arranged to provide an output current which is an analogue of the current to be measured.
10/09/14
20140303260
Pharmaceutical compositions of resveratrol
A pharmaceutical composition for administering a therapeutically effective amount of resveratrol or a functionally equivalent analogue or derivative thereof to a subject. The absorption of resveratrol occurs through the subject's buccal/sublingual membranes, thereby by-passing first pass metabolism by the liver..
10/09/14
20140303166
Cosmetic method for changing the appearance of eyes
The current application is directed to cosmetic methods for changing the appearance of eyes by causing a retraction of the eyelids so that the eyes appear to be more open and have a wider appearance. Various methods involve application of one or more prostaglandins, synthetic prostaglandins, including synthetic prostaglandin f, and synthetic prostaglandin analogues, to eyelids, which results in contraction of eyelid muscles and a wider, more open appearance of the eyes..
10/09/14
20140303082
Selective gpcr ligands
In the past decade a great deal of structural information for class a-gpcrs (g protein-coupled receptors) has emerged. However, the structural and electronic basis of ligand selectivity for closely related receptor subtypes such as the angiotensin receptors at1ar and at2r, which present completely diverse biological functions in response to the same ligand, is poorly understood.
10/09/14
20140303076
Non-standard insulin analogues
An insulin analogue comprises a b-chain polypeptide containing a cyclohexanylalanine substitution at position b24 and optionally containing additional amino-acid substitutions at positions a8, b28, and/or b29. A proinsulin analogue or single-chain insulin analogue containing a b domain containing a cyclohexanylalanine substitution at position b24 and optionally containing additional amino-acid substitutions at positions a8, b28, and/or b29.
10/09/14
20140302553
Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
Disclosed herein is pyrroline-carboxy-lysine (pcl), a pyrrolysine analogue, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating pcl. Also disclosed herein are proteins, polypeptides and peptides that have pcl incorporated therein and methods for incorporating pcl into such proteins, polypeptides and peptides.
10/02/14
20140296567
3-hydroxyanthranilic acid (3-haa) therapy for prevention and treatment of hyperlipidemia and its cardiovasular complications
The present invention relates to the use of a tryptophan metabolite, 3-hydroxyanthranilic acid (3-haa) or a functional analogue thereof, for prophylactic and/or therapeutic treatment of mammals, in special humans, against hyperlipidemia and its cardiovascular complications, i.e. Atheroma formation, myocardial infarction and heart failure, ischemic stroke and transient ischemic attacks, renal impairment, aortic aneurysms and critical limb ischemia caused by atherosclerosis..
10/02/14
20140296307
Potent analogues of the c-myc inhibitor 10074-g5 with improved cell permeability
The present invention relates compounds and compositions for interfering with the association of myc and max. These compounds and compositions are useful in methods for inhibiting growth or proliferation of a cell.
10/02/14
20140296230
Dihydroquinazolinone analogues
Wherein the groups r1 to r4 and a1 to a5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament..
10/02/14
20140296229
Indolinone analogues
Wherein the groups r1 to r4, a1 and a2 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament..
10/02/14
20140296166
Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
The present invention provides for methods and compositions for treating, reducing and/or preventing cardiac dysfunction by administering to subject a therapeutically effective amount of a bisphosphonate, prodrug thereof, functional analogue or a pharmaceutically effective salt thereof in an amount sufficient to increase activity of at least one kinase in heart tissue of the subject.. .
10/02/14
20140296141
Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus
The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of hiv, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from pparγ2, lpl and αp2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.
10/02/14
20140296131
Truncated glp-1 derivatives and their therapeutical use
The invention relates to truncated glp-1 analogues, in particular a glp-1 analogue which is a modified glp-1(7-35) (seq id no 1) having: i) a total of 2, 3, 4, 5 6, 7, 8, or 9 amino acid substitutions as compared to glp-1(7-35), including a) a glu residue at a position equivalent to position 22 of glp-1(7-35), and b) an arg residue at a position equivalent to position 26 of glp-1(7-35); as well as derivatives thereof, and therapeutic uses and compositions. These analogues and derivatives are highly potent, have a good binding affinity to the glp-1 receptor, also to the extracellular domain of the glp-1 receptor, which is of potential relevance achieving long-acting, stable glp-1 compounds with a potential for once weekly administration..
10/02/14
20140295550
Hla peptide therapy
The invention provides polypeptides derived from a major histocompatibility complex (mhc) class i human leukocyte antigen (hla), such as hla-a2, and derivatives or analogues thereof. The polypeptides, derivatives and analogues can be used to treat or prevent allosensitisation, such as the treatment or prevention of allograft rejection..
10/02/14
20140295414
Methods and compositions for labeling nucleic acids
The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. In particular, the methods include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label.
10/02/14
20140295372
Device of computerized dental measurement and measuring method usable with said device
This device comprises a measuring clamp (1) for teeth (20) and dental spaces (21), comprising a set of mobile arms (2) ending in some exploration extremities (3), which exploring displacement along the teeth (20) and dental spaces (21) determines the joint displacement of the mobile arms (2). A transducer (11) turns the relative displacement movement between mobile arms (2), into signals (25) expressing the positional parameters (23) determined by that movement, and, upon being connected to a computerized system (30), it transmits the signals (25) for their processing as measurement parameters (23).
10/02/14
20140295280
Mgmn2o4 with a crystal structure analogue to cafe2o4, camn2o4, or cati2o4 as rechargeable magnesium battery cathode
A cathode active material for a battery includes a material of the formula mgxmn2o4 wherein 0≦x≦1 and the material has a crystal structure having an open channel formed in a single dimension or along a single dimensional axis. The crystal structure may be an analogue to cafe2o4, camn2o4 or cati2o4..
10/02/14
20140294931
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
Thyroid hormone antagonists and their nanoparticle formulations (nanotetrac™ or nanotriac™) act at a cell surface receptor to block angiogenesis and tumor cell proliferation. The complex anti-angiogenic performs actions on specific cytokines and chemokines.
10/02/14
20140294897
Potent lna oligonucleotides for the inhibition of hif-1a expression
The present disclosure relates to an lna oligonucleotide consisting of a sequence selected from the group consisting of 5′-(tx)gxgxcsasasgscsastscscstxgxt-3′ and 5′-(gx)txtxascstsgscscststscstxtxa-3′, wherein capital letters designate a beta-d-oxy-lna nucleotide analogue, small letters designate a 2-deoxynucleotide, underline designates either a beta-d-oxy-lna nucleotide analogue or a 2-deoxynucleotide, subscript “s” designates a phosphorothioate link between neighbouring nucleotides/lna nucleotide analogues, and subscript “x” designates either a phosphorothioate link or a phosphorodiester link between neighbouring nucleotides/lna nucleotide analogues, and wherein the sequence is optionally extended by up to five 2-deoxynucleotide units. The lna oligonucleotides are useful for modulating the expression of hypoxia-inducible factor-1a (hif-1a), e.g.
09/25/14
20140288962
Multi-media medical notes system (mmmns)
This invention develops a multi-media medical notes system (mmmns) that allows for the creation of the medical notes and integration with the medical records data bases. Its purpose is to provide an electronic format where the notes created during a patient's admission regarding daily examinations normally noted in analogue form could be organized to improve their presentation, accessibility, and integration.
09/25/14
20140288880
Sensor based means of monitoring the mechanical condition of rotating machinery that operates intermittently
A method of monitoring the mechanical condition of a machine in which statistically significant measurements on a characteristic signal are made over a period of time which can include interruptions and variations in the operation of the machine giving rise to uncharacteristic signals and the processing of the signal during the statistically significant measurement automatically excludes those parts of the signal associated with interruptions and variations in the operation of the machine. The invention also includes apparatus for carrying out the above method including a preamplifier, adapted to provide output to a further amplifier, adapted to provided output to dynamic enveloping circuitry, adapted to provide an output to an analogue to digital converter, adapted to provide an output to a digital micro-electronic device..
09/25/14
20140288862
Magnetic compensation circuit and method for compensating the output of a magnetic sensor, responding to changes in a first magnetic field
A solution for compensating a magnetic field sensor to permit detection of a small magnetic field in the presence of a large magnetic field is disclosed. A magnetic field sensor detects the magnetic field which produces an analogue signal then encoded by an analogue to digital converter (adc) into a digital stream.
09/25/14
20140288266
Synthesis of cyclosporin analogs
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine a. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives.
09/25/14
20140288052
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.


Popular terms: [SEARCH]

Analogue topics: Carbon Dioxide, Amino Acid, Radio Signal, Inorganic Compounds, Hydrogen Production From Water, Electrolysis, Semiconductor, High Energy, Semiconductor Material, Transmitter, Synchronization, Concurrent, Surfactant, Hyperglycemia, Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Analogue for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Analogue with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.4089

3367

449990 - 0 - 76